Clinical Trial Update: Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy and safety of a fixed-dose combination of brinzolamide and brimonidine given twice daily versus separate brinzolamide and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• ALPHAGAN P (BRIMONIDINE TARTRATE)
• Azopt (brinzolamide)
• Simbrinza (brinzolamide/brimonidine)

Snippet

Sponsor: Alcon Research | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2017-09-07